Summarized by Masters of Longevity from UT Southwestern.
This science news article previews research on how a specific tumor-linked metabolite can stimulate neurons to support aggressive brain cancer, and outlines planned patient-focused dietary testing.
Key Takeaways
- Researchers found up to 100-fold accumulation of guanidinoacetate in aggressive adult gliomas compared with normal tissue.
- Blocking the enzyme that produces guanidinoacetate reduced neuronal activity and slowed tumor growth in laboratory models.
- A clinical trial will test a dietary therapy used for GAMT deficiency to lower tumor guanidinoacetate before surgery.
